The Blueberry Study
Plasma and Urine Profiles of Blueberry Derived Polyphenols After a Short Term Intervention With Blueberry in Children With Typical Low Fruit and Vegetable Consumption.
3 other identifiers
interventional
44
1 country
1
Brief Summary
This is a research study about the effects of blueberries on the health of children who do not eat much fruits and vegetables. By doing this study, we hope to find out what nutrients from blueberries appear in the blood and urine of the child
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Apr 2021
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedStudy Start
First participant enrolled
April 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 18, 2022
CompletedResults Posted
Study results publicly available
August 22, 2025
CompletedAugust 22, 2025
September 1, 2024
1.3 years
May 26, 2020
September 12, 2024
August 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Phenolic Acid Metabolites Measured in Plasma and Urine After Dietary Intervention
Fasting Blood and urine were collected at visit two and three following an overnight fasting. At visit three, children consumed a single dose of the study product and plasma and urine were collected
Measurements were conducted hourly for 5 hours; the cumulative number of metabolites characterized over the 5 hours is reported
Secondary Outcomes (3)
Number and Percentage of Lymphocytes Cluster of Differentiation 4 (CD4), Lymphocytes Cluster of Differentiation 8 (CD8) and Natural Killer (NK) Cells
up to 2 weeks
T-lymphocyte Responsiveness to Immune Stressors
up to 2 weeks
Endothelial Function by Brachial Artery Flow Mediated Dilation
up to 2 weeks
Study Arms (2)
Wild Blueberry Supplement
ACTIVE COMPARATOR30 grams of wild blueberry powder per day in foods items provided to them
Placebo supplement
PLACEBO COMPARATORFood items will be provided to them without the wild blueberry power.
Interventions
Foods that contain wild blueberry supplement to deliver up to 30 grams of blueberry powder
Foods that do not contain the blueberry powder but a placebo
Eligibility Criteria
You may qualify if:
- Eats \<1.5 cup of fruit and \<2.0 cup of vegetables per day
- Boys or girls
- All ethnicities
- All BMIs
You may not qualify if:
- Known allergy to blueberries
- Epilepsy
- Asthma
- Chronic kidney disease
- Hormonal disease
- Autoimmune disease
- Bleeding disorders
- Chronic infections
- Type 2 and Type 1 diabetes mellitus
- Attention deficit hyperactivity disorder
- Opposition defiant disorder
- Autistic spectrum disorder
- Pre-existing medical conditions or medications as determined by the investigators to affect the outcomes of interest
- If the participants/parents perceive barriers with adhering to low-polyphenol meals
- Parent or child refusal to stop nutritional supplements
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arkansas Children's Nutrition Center
Little Rock, Arkansas, 72202, United States
Results Point of Contact
- Title
- Eva C. Diaz, Principal Investigator
- Organization
- University of Arkansas for Medical Sciences and Arkansas Children's Nutrition Ce
Study Officials
- PRINCIPAL INVESTIGATOR
Eva Diaz, MD
Arkansas Children's Reserach Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- Double blinded randomized control
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2020
First Posted
June 9, 2020
Study Start
April 23, 2021
Primary Completion
August 18, 2022
Study Completion
August 18, 2022
Last Updated
August 22, 2025
Results First Posted
August 22, 2025
Record last verified: 2024-09